CFTR and cystic fibrosis: Additionally, recent data has demonstrated that CFTR modulators such as ivacaftor, which is commonly utilized in the treatment of CF, may synergize with fluoroquinolones against biofilm-producing Psa and enhance bacterial killing [5].